drugset / Trial / NCT01791400

Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache

NCT01791400

Phase 2 Completed 124 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine which drug makes lower migraine headache

Timeline

Start
2009-07
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 20 mg Intravenous
Subject Sumatriptan Unknown 6 mg Subcutaneous

Indications